Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | ETX-19477 |
| Synonyms | |
| Therapy Description |
ETX-19477 inhibits PARG, resulting in the accumulation of PAR chains and potentially leading to cell death and tumor growth inhibition (Cancer Res (2024) 84 (6_Supplement): 2083). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| ETX-19477 | ETX-19477 inhibits PARG, resulting in the accumulation of PAR chains and potentially leading to cell death and tumor growth inhibition (Cancer Res (2024) 84 (6_Supplement): 2083). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06395519 | Phase I | ETX-19477 | A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies (ERADIC8) | Recruiting | USA | 0 |